Asia Pacific Bariatric Surgeries Market Forecast to 2030 - Regional Analysis - by Type and End User

The Asia Pacific bariatric surgeries market was valued at US$ 913.53 million in 2022 and is expected to reach US$ 3,115.01 million by 2030; it is estimated to grow at a CAGR of 16.6% from 2022 to 2030.

Strategic Initiatives by Market Players Fuels the Asia Pacific Bariatric Surgeries Market

There has been a constant increase in the prevalence of obesity on a global level that has increased the demand for bariatric surgery devices. Various market players are also focused on product launches or strategic collaborations for the development of advanced products that help during bariatric surgeries and provide positive outcomes. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below: In November 2022, Boston Scientific Corporation acquired Apollo Endosurgery Inc. with a total value of approximately US$ 615 million, which indicated a cash price of US$ 10 per share. The Apollo Endosurgery product portfolio includes devices used during endoluminal surgery (ELS) procedures to close and manage gastrointestinal defects and complications, along with aid in weight loss for patients with obesity. In September 2021, Olympus acquired the new advanced bipolar surgical energy product range known as POWERSEAL. The POWERSEAL 5 mm Curved Jaw Tissue Sealer and Divider is a double-action device that meets the highest standards of medical performance for advanced bipolar surgical energy devices by delivering constant sealing reliability in an ergonomic and multifunctional design that promotes procedural efficiency. The POWERSEAL devices can be employed in numerous surgical procedures, including general, gynaecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.

Thus, a surge in product launches, development, and strategic collaborations is likely to create considerable growth opportunities for the bariatric surgery devices market in the future.

Asia Pacific Bariatric Surgeries Market Overview

The Asia Pacific bariatric surgeries market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the bariatric surgeries market is widely driven by company collaborations, increasing prevalence of obesity, and growing demand for minimally invasive surgeries. Due to the growing obese population in China, bariatric surgeries are gaining significant traction in the country. Other factors such as growing diabetes, rising cases of cardiovascular diseases (CVDs), and developments by the market players are also majorly contributing to the growth of bariatric surgery devices in the country, making it a significant market in Asia Pacific.

In September 2022, according to the Global Health Journal, obesity has become a severe public health issue worldwide. China has the world's largest number of overweight people. Over 50% of adults and about 20% of children and adolescents in China are overweight. Over the past 20 years, China has taken many actions in obesity intervention, and obesity rates have continued to grow. Thus, the demand for bariatric surgeries is growing in China.

Several market players are adopting organic strategies to stay competitive in the market. For instance, in September 2021, Olympus launched the POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider. The devices fulfil the highest clinical performance standards for advanced bipolar surgical energy devices by delivering consistent sealing reliability in an ergonomic, multifunctional design that encourages procedural efficiency.

The factors mentioned above are likely to continue to boost the growth of the bariatric surgery devices market in China.

Asi

a Pacific Bariatric Surgeries Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Bariatric Surgeries Market Segmentation

The Asia Pacific bariatric surgeries market is segmented into type, end user, and country.

Based on type, the Asia Pacific bariatric surgeries market is categorized adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (bpd- ds), and others. The sleeve gastrectomy market segment held the largest share in 2022.

In terms of end user, the Asia Pacific bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospitals segment held a larger share in 2022.

Based on country, the Asia Pacific bariatric surgeries market is segmented China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific bariatric surgeries market in 2022.

Conmed Corp, Integra LifeSciences Holdings Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, and Reshape Lifesciences Inc are some of the leading companies operating in the Asia Pacific bariatric surgeries market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bariatric surgeries market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific bariatric surgeries market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution